EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Design and Synthesis of Novel Candidate CK1δ Proteolysis Targeting Chimeras (PROTACs)

Malte Arnold iD, Temi Thompson, Lorraine Glennie, Mattes Hollnagel, Gopal Sapkota iD, Christian Peifer iD

Molecules · 2025

DOI: 10.3390/molecules30224452 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Malte Arnold und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmacy, Department of Pharmaceutical and Medicinal Chemistry, Christian-Albrechts-University of Kiel, 24118 Kiel, Germany. Hauptthemen laut MEDLINE: Proteolysis, Casein Kinase Idelta, Drug Design. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UKRI Medical Research Council, University of Dundee’s Black British Scholarship Programme, MRC PPU Prize PhD studentship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The dysregulation of CK1 isoforms is linked to various types of diseases, including neurodegeneration and different types of neoplasia such as colon, pancreatic, breast, and ovarian cancer. For CK1 isoforms, a plethora of effective small molecule inhibitors are available. However, only a few degraders of CK1α and, more recently, proteolysis targeting chimeras (PROTACs) for CK1δ/CK1ε have been reported. In this study, we applied the PROTAC concept by harnessing molecular modelling to design and synthesize a series of candidate CK1δ-targeting PROTACs based on a highly specific and potent benzothiazole-based CK1δ inhibitor that we previously developed in our lab. In the present study, we established a modular synthetic platform to systematically generate a set of PROTAC degrader candidates consisting of the CK1δ-specific inhibitor scaffold, alkyl and PEG linker motifs with various lengths, and Cereblon (CRBN)-engaging pomalidomide and thalidomide derivatives as E3 ligase binders. We demonstrate that several PROTACs degrade CK1δ/ε in various cells. The most potent PROTAC P1d inhibits the phosphorylation of downstream substrates through CK1δ/ε degradation. We establish the requirement of CUL4ACRBN and the proteasome for the P1d-mediated degradation of CK1δ/ε.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProteolysisCasein Kinase IdeltaDrug DesignHumansUbiquitin-Protein LigasesProteasome Endopeptidase ComplexThalidomidePhosphorylationBenzothiazolesModels, MolecularProteolysis Targeting ChimeraAdaptor Proteins, Signal Transducing

Stichwörter der Autor:innen

CK1δPROTACscancer therapykinasesprotein degradation

Substanzen

Casein Kinase IdeltaUbiquitin-Protein LigasesProteasome Endopeptidase ComplexThalidomideCRBN protein, humanBenzothiazolesProteolysis Targeting ChimeraAdaptor Proteins, Signal Transducing

Autor:innen und Institutionen

  • Institute of Pharmacy, Department of Pharmaceutical and Medicinal Chemistry, Christian-Albrechts-University of Kiel, 24118 Kiel, Germany.
  • MRC Protein Phosphorylation and Ubiquitylation Unit, Sir James Black Centre, School of Life Sciences, University of Dundee, Dundee DD1 5EH, Scotland, UK.

ORCID-Profile: Malte Arnold, Gopal Sapkota, Christian Peifer

Förderung

  • UKRI Medical Research Council
  • University of Dundee’s Black British Scholarship Programme
  • MRC PPU Prize PhD studentship

Zitieren

APA

Arnold, M., Thompson, T., Glennie, L., Hollnagel, M., Sapkota, G., & Peifer, C. (2025). Design and Synthesis of Novel Candidate CK1δ Proteolysis Targeting Chimeras (PROTACs). Molecules. https://doi.org/10.3390/molecules30224452

Vancouver

Arnold M, Thompson T, Glennie L, Hollnagel M, Sapkota G, Peifer C. Design and Synthesis of Novel Candidate CK1δ Proteolysis Targeting Chimeras (PROTACs). Molecules. 2025. doi:10.3390/molecules30224452

BibTeX
@article{Arnold2025,
  author = {Arnold, Malte and Thompson, Temi and Glennie, Lorraine and Hollnagel, Mattes and Sapkota, Gopal and Peifer, Christian},
  title = {Design and Synthesis of Novel Candidate CK1δ Proteolysis Targeting Chimeras (PROTACs)},
  journal = {Molecules},
  year = {2025},
  doi = {10.3390/molecules30224452}
}
Kostenlos starten →